The Hydroxyurea Capsules, cataloged under National Stock Number 6505-00-481-1788, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Avkare Llc. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-00-481-1788 |
| Primary Part Number | NDC42291-0321-01 |
| Item Name | Hydroxyurea Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Avkare Llc |
| Status | ACTIVE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Protective Storage Feature | ANTINEOPLASTIC DRUG |
| Capsule Primary Container Content Quantity | 100.000 |
| Capsule Content Form | POWDER |
| Active Medicament Medicinal Strength | 500.000 MILLIGRAMS HYDROXYUREA ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC42291-0321-01 PRIMARY | Avkare Llc (USA) |
| NDC49884-0724-01 PRIMARY | Par Pharmaceutical, Inc. Dba Par Pharmaceutical (USA) |
| Reference | Meaning |
|---|---|
| 00003083050 | 5/9 Secondary reference Bristol-Myers Squibb Company Dba Bristol-Myers Squibb |
NSN 6505-00-481-1788 is a Hydroxyurea Capsules, manufactured by Avkare Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-00-481-1788 has 2 manufacturer part numbers on file: NDC42291-0321-01 (Avkare Llc), NDC49884-0724-01 (Par Pharmaceutical, Inc. Dba Par Pharmaceutical).
Key specifications for NDC42291-0321-01: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Protective Storage Feature: ANTINEOPLASTIC DRUG; Capsule Primary Container Content Quantity: 100.000. 6 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.